MK0954, /Duration of Treatment : 5 Years + Comparator : atenolol /Duration of Treatment : 5 Years
Phase 3CompletedDevelopment Stage
Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
Jun 1, 1995 → Nov 1, 2001
About MK0954, /Duration of Treatment : 5 Years + Comparator : atenolol /Duration of Treatment : 5 Years
MK0954, /Duration of Treatment : 5 Years + Comparator : atenolol /Duration of Treatment : 5 Years is a phase 3 stage product being developed by Organon for Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart). The current trial status is completed. This product is registered under clinical trial identifier NCT00338260. Target conditions include Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart).
Hype Score Breakdown
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00338260 | Phase 3 | Completed |
Competing Products
20 competing products in Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)